Skip to main content
Borosil Scientific Limited logo

Borosil Scientific Limited — Investor Relations & Filings

Ticker · BOROSCI ISIN · INE02L001032 LEI · 9845000KHFF9A4F3BF28 BSE.NS Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2024-11-28 Regulatory Filings
Country IN India
Listing BSE.NS BOROSCI

About Borosil Scientific Limited

https://www.borosilscientific.com

Borosil Scientific Limited specializes in the manufacture and distribution of high-quality laboratory glassware and scientific instruments. The company provides a comprehensive range of products, including beakers, flasks, cylinders, pipettes, and specialized laboratory apparatus designed for precision and durability. Its offerings cater to diverse sectors such as pharmaceuticals, biotechnology, research and development, and educational institutions. Utilizing advanced borosilicate glass technology, the company ensures its products exhibit superior thermal shock resistance and chemical durability. In addition to glassware, the portfolio includes laboratory equipment and primary packaging solutions for the healthcare industry. Borosil Scientific Limited is recognized for its commitment to accuracy and international quality standards, supporting critical scientific processes and industrial applications.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announcing the introduction of a Voluntary Retirement Scheme (VRS) by the company. It is an announcement of a corporate action related to workforce management and cost optimization, not a financial report or detailed management discussion. The document is short (1467 characters) and serves as a regulatory announcement to stock exchanges. It does not contain financial statements, audit information, or detailed management commentary. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-28 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is an official communication to stock exchanges (BSE and NSE) regarding the allotment of equity shares following the exercise of stock options under the company's ESOP scheme. It details the number of shares allotted, the increase in issued share capital, regulatory approvals, and disclosures as per SEBI regulations. The document includes annexures with detailed disclosures about the share issue under the ESOP scheme. This is a notification about a share capital change due to ESOP exercise and allotment, not a full financial report or earnings release. It is not a report publication announcement since it contains substantive information about the share allotment event itself. Therefore, the document fits the category of Share Issue/Capital Change (SHA).
2024-11-26 English
Updates
Investor Presentation Classification · 100% confidence The document is an investor presentation dated November 14, 2024, regarding the unaudited financial results for the quarter and half year ended September 30, 2024. It includes detailed financial data such as net sales, EBITDA, EBIT, PBT, PAT, and segment-wise sales for Q2FY25 and H1FY25. The document also contains company background, business segments, and strategic information typical of investor presentations. It is not a formal earnings release (which would be shorter and more headline-focused), nor is it a full annual or interim report. The presence of detailed financial and business information aimed at investors confirms it is an Investor Presentation (IP). The document length (15,000 characters) and content confirm it is the presentation itself, not just an announcement of a report. Therefore, the correct classification is Investor Presentation (IP).
2024-11-14 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of an extract of unaudited financial results for the quarter and half year ended September 30, 2024. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of financial results. The document includes a newspaper advertisement extract of these unaudited financial results. The content is focused on announcing the publication of financial results in newspapers rather than providing the full financial report itself. The document length is 15,000 characters, which is substantial, but the content is primarily an announcement of the financial results extract publication, not the full interim or quarterly report with detailed financial statements and analysis. Therefore, it fits best as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication, not the full Interim/Quarterly Report (IR) or Earnings Release (ER).
2024-11-13 English
Financial Result Updates
Regulatory Filings
2024-11-12 English
Change in Director(s)
Regulatory Filings
2024-11-12 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.